Cargando…

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma

BACKGROUND: Temozolomide (TMZ) has been the standard-of-care chemotherapy for glioblastoma (GBM) patients for more than a decade. Despite this long time in use, significant questions remain regarding how best to optimize TMZ therapy for individual patients. Understanding the relationship between TMZ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Massey, Susan Christine, White, Haylye, Whitmire, Paula, Doyle, Tatum, Johnston, Sandra K., Singleton, Kyle W., Jackson, Pamela R., Hawkins-Daarud, Andrea, Bendok, Bernard R., Porter, Alyx B., Vora, Sujay, Sarkaria, Jann N., Hu, Leland S., Mrugala, Maciej M., Swanson, Kristin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100932/ https://www.ncbi.nlm.nih.gov/pubmed/32218600 http://dx.doi.org/10.1371/journal.pone.0230492

Ejemplares similares

Shape matters: morphological metrics of glioblastoma imaging abnormalities as biomarkers of prognosis
por: Curtin, Lee, et al.
Publicado: (2021)

Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies
por: Singleton, Kyle W, et al.
Publicado: (2020)

Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients
por: Whitmire, Paula, et al.
Publicado: (2020)

Quantifying Uncertainty and Robustness in a Biomathematical Model–Based Patient-Specific Response Metric for Glioblastoma
por: Hawkins-Daarud, Andrea, et al.
Publicado: (2019)

Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma
por: Hu, Leland S., et al.
Publicado: (2021)

TRANSLATIONAL RESEARCH-03 MULTIPLE MECHANISMS MODULATE TEMOZOLOMIDE RESISTANCE AND ARE POTENTIAL TARGETS FOR GLIOBLASTOMA THERAPY.
por: Kitange, Gaspar, et al.
Publicado: (2023)

Comprehensive Commissioning and Clinical Implementation of GammaTiles STaRT for Intracranial Brain Cancer
por: Penoncello, Gregory P., et al.
Publicado: (2022)

Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care
por: Curtin, Lee, et al.
Publicado: (2020)

Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms
por: Fega, Kathryn R., et al.
Publicado: (2018)

Quantifying Glioblastoma Drug Response Dynamics Incorporating Treatment Sensitivity and Blood Brain Barrier Penetrance From Experimental Data
por: Massey, Susan Christine, et al.
Publicado: (2020)

LZTR1‐related spinal schwannomatosis and 7q11.23 duplication syndrome: A complex phenotype with dual diagnosis
por: Muthusamy, Karthik, et al.
Publicado: (2020)

Towards Longitudinal Glioma Segmentation: Evaluating combined pre- and post-treatment MRI training data for automated tumor segmentation using nnU-Net
por: Ranjbar, Sara, et al.
Publicado: (2023)

Modeling Tumor-Associated Edema in Gliomas during Anti-Angiogenic Therapy and Its Impact on Imageable Tumor
por: Hawkins-Daarud, Andrea, et al.
Publicado: (2013)

Patient-Specific Mathematical Neuro-Oncology: Using a Simple Proliferation and Invasion Tumor Model to Inform Clinical Practice
por: Jackson, Pamela R., et al.
Publicado: (2015)

A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using (18)F-FMISO-PET
por: Rockne, Russell C., et al.
Publicado: (2015)

Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
por: Khan, Muhammad Babar, et al.
Publicado: (2021)

Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells
por: Harder, Bryan G., et al.
Publicado: (2019)

From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response
por: Gallaher, Jill A., et al.
Publicado: (2020)

In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma
por: Hawkins-Daarud, Andrea, et al.
Publicado: (2015)

Detection of temozolomide-induced hypermutation and response to PD-1 checkpoint inhibitor in recurrent glioblastoma
por: Daniel, Paul, et al.
Publicado: (2022)

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
por: Chen, Xiaoyue, et al.
Publicado: (2018)

TIPS-09 FIRST-IN-HUMAN PHASE 1 TRIAL OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTI-TUMOR ACTIVITY OF WSD0922-FU (NCT04197934): TRIAL IN PROGRESS
por: Kizilbash, Sani, et al.
Publicado: (2023)

From Patient-Specific Mathematical Neuro-Oncology to Precision Medicine
por: Baldock, A. L., et al.
Publicado: (2013)

Targeted c-Myc Inhibition and Systemic Temozolomide Therapy Extend Survival in Glioblastoma Xenografts
por: Dhungel, Laxmi, et al.
Publicado: (2023)

Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI
por: Gaw, Nathan, et al.
Publicado: (2019)

Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas
por: Baldock, Anne L., et al.
Publicado: (2014)

Lung cancer with brain metastases remaining in continuous complete remission due to pembrolizumab and temozolomide: a case report
por: Zhu, Xianmin, et al.
Publicado: (2022)

Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric
por: Neal, Maxwell Lewis, et al.
Publicado: (2013)

Identifying the spatial and temporal dynamics of molecularly-distinct glioblastoma sub-populations
por: Morris, Bethan, et al.
Publicado: (2020)

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
por: Vieito, Maria, et al.
Publicado: (2022)

Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
por: Faye, Mame Daro, et al.
Publicado: (2023)

Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
por: Wen, Qiuting, et al.
Publicado: (2014)

Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures
por: Hu, Leland S., et al.
Publicado: (2023)

Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation
por: Wong, Eric T, et al.
Publicado: (2015)

Characterization of relative biological effectiveness for conventional radiation therapy: a comparison of clinical 6 MV X-rays and (137)Cs
por: Howard, Michelle, et al.
Publicado: (2017)

Perivascular Stromal Cells Instruct Glioblastoma Invasion, Proliferation, and Therapeutic Response within an Engineered Brain Perivascular Niche Model
por: Ngo, Mai T., et al.
Publicado: (2022)

Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma
por: Thomson, Holly M, et al.
Publicado: (2023)

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)

HGG-10. Efficacy of convection-enhanced delivery of GB-13 (IL13.E13K-PE4E) in an orthotopic xenograft model of high-grade glioma is predicated on IL-13Rα2 expression.
por: Rechberger, Julian, et al.
Publicado: (2022)

Weakly Supervised Skull Stripping of Magnetic Resonance Imaging of Brain Tumor Patients
por: Ranjbar, Sara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0p71kaegp0gd7smqb6kcko7aem